Receptor specific transepithelial transport of immunogens
US6086875A · kind A · utility
198Cited by
16References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 17, 1995 |
| Grant date | Jul 11, 2000 |
| Priority date | — |
| Expiry date | Jan 17, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and products for modulating an immune response are provided. Pharmaceutical preparations contain a conjugate of an antigen and a FcRn binding partner. The conjugates are administered to mammals in effective amounts to modulate the immune system by stimulating the immune response against the antigen or tolerizing the immune system to the antigen. The antigen may be characteristic of a pathogen, of an autoimmune disease or of an allergen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.